January 31, 2018
Nuformix wraps up pilot study for its NXP002 for treating fibrosis
Nuformix has completed pilot pre-clinical studies that further validate the potential for its NXP002 programme in successfully and safely treating…
Pharmaceuticals, Biotechnology and Life Sciences
Nuformix has completed pilot pre-clinical studies that further validate the potential for its NXP002 programme in successfully and safely treating…
Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs, said on…